Pseudoephedrine urolithiasis associated with acute renal failure [4]

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 263-264

  Smith, Charles L ^a,b   Gemar, Sheila K ^a,b   Lewis, Matthew J ^a,b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b Division of Urology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; EPHEDRINE; GUAIFENESIN; IBUPROFEN; PSEUDOEPHEDRINE;

ACUTE KIDNEY FAILURE; ADULT; BACKACHE; CALCIUM EXCRETION; CASE REPORT; DISEASE ASSOCIATION; HUMAN; HYDRONEPHROSIS; HYPERCALCIURIA; KIDNEY FUNCTION; LETTER; MALE; NAUSEA; NEPHROLITHIASIS; PERIPHERAL EDEMA; PRIORITY JOURNAL; RISK FACTOR; ULTRASOUND; URETER STENT; UROLITHIASIS; VOMITING;

ADRENERGIC AGENTS; ADULT; EPHEDRINE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; URINARY CALCULI;

EID: 0347917047     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg510     Document Type: Letter

References (5)

1. Hess B. Drug-induced urolithiasis. Curr Opin Urol 1988; 8: 331-334
2. Blau JJ. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J Urol 1998; 160 [3 Pt 1]: 825
3. Powell T, Hsu FF, Turk J, Hruska K. Ma-Huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis 1998; 32: 153-159
4. Assimos DG, Langenstroer P, Leinbach RF, Mandel NS, Stern JM, Holmes RP. Guaifenesin- and ephedrine-induced stones. J Endourol 1999; 13: 665-667
5. Pickens CL, Milliron AR, Fussner A et al. Abuse of guaifenesin-containing medications generates an excess of a carboxylate salt of beta-(2-methoxyphenoxy)-lactic acid, a guaifenesin metabolite, and results in urolithiasis. Urology 1999; 54: 23-27